Download
zyprexa documents ppt 1 n.
Skip this Video
Loading SlideShow in 5 Seconds..
Zyprexa documents ppt 1. PowerPoint Presentation
Download Presentation
Zyprexa documents ppt 1.

Zyprexa documents ppt 1.

443 Views Download Presentation
Download Presentation

Zyprexa documents ppt 1.

- - - - - - - - - - - - - - - - - - - - - - - - - - - E N D - - - - - - - - - - - - - - - - - - - - - - - - - - -
Presentation Transcript

  1. Zyprexa documents ppt 1. This powerpoint has a selection of pages from documents to do with marketing issues.

  2. What are the “Zyprexa Documents” • Class action court case v Eli-Lilly re alleged with-holding of ADEs data (wght gain and diabetes) and off-label marketing (dementia and subsyndromal mood swings). • Subpoenaed internal company documents. • Lawyer (Gottstein), public health physician expert witness (Egilman), New York Times journalist (Berenson) December 2006. • 358 files, copious data re int memos, powerpoint pres, marketing strategies… • Website www.furiousseasons.com (Dawdy) and a German website. • Judge ordered cannot be retrieved from internet.

  3. What are the “Zyprexa Documents” • Heavily downloaded from furiousseasons.com • Form basis of journalist articles and web-blog analyses. • Paper for academic literature (Spielmans) • Provide insight into the goals and functioning of a big pharmaceutical company.

  4. Issues raised • Marketing for “NCE’s” (New Clinical Entities) and off-label indications. • Alternatively described as “Disease Mongering” to increase sales. • Damage control, use of “spin”, possible concealment re ADEs. • Sophistication of pharma companies in interacting with (controlling?) “customers”. = physicians, pharmacists, hospitals/govt, allied health, patient advocacy groups.

  5. ZY100035541 Olanzapine Lifeplan • The “Safer Clozapine” • Market is Schizophrenia. • No mention of bipolar or dementia.

  6. ZY100035541 Olanzapine Lifeplan

  7. The “Safer Clozapine” Market is Schizophrenia. No mention of bipolar or dementia. ZY100035541 Olanzapine Lifeplan

  8. ZY100035541 Olanzapine Lifeplan

  9. Prozac patent due to expire August 2001. ZY201548768 Betting the Farm

  10. ZY201548768 Betting the Farm

  11. ZY200270343 Zyprexa Product Team summary 1997

  12. ZY200270343 Zyprexa Product Team summary 1997

  13. ZY200270343 Zyprexa Product Team summary 1997

  14. ZY200270343 Zyprexa Product Team summary 1997

  15. ZY200270343 Zyprexa Product Team summary 1997

  16. ZY200270343 Zyprexa Product Team summary 1997

  17. ZY200270343 Zyprexa Product Team summary 1997

  18. ZY200270343 Zyprexa Product Team summary 1997

  19. ZY200270343 Zyprexa Product Team summary 1997

  20. ZY200270343 Zyprexa Product Team summary 1997

  21. ZY200270343 Zyprexa Product Team summary 1997

  22. ZY200270343 Zyprexa Product Team summary 1997

  23. ZY200270343 Zyprexa Product Team summary 1997

  24. ZY200270343 Zyprexa Product Team summary 1997

  25. ZY100041262 PCP opportunity

  26. ZY100041262 PCP opportunity

  27. ZY100041262 PCP opportunity

  28. ZY100520662 Zyprexa primary care briefing document 21July2000

  29. ZY100520662 Zyprexa primary care briefing document 21July2000

  30. ZY100520662 Zyprexa primary care briefing document 21July2000

  31. ZY100520662 Zyprexa primary care briefing document 21July2000

  32. ZY100520662 Zyprexa primary care briefing document 21July2000

  33. ZY100582035 Zyprexa Complicated Mood Project date?

  34. ZY201797499 email re driving depression story since 98 Feb 2000

  35. ZY200083405 PCP vision

  36. ZY200083405 PCP vision

  37. ZY200083405 PCP vision

  38. ZY200083405 PCP vision

  39. ZY200083405 PCP vision

  40. ZY100040886 Primary Care Physician strategy

  41. ZY100040886 Primary Care Physician strategy

  42. ZY100040886 Primary Care Physician strategy

  43. ZY100040886 Primary Care Physician strategy

  44. ZY200083622 Addressing PCP FAOC

  45. ZY200083622 Addressing PCP FAOC

  46. ZY200083622 Addressing PCP FAOC

  47. ZY200083622 Addressing PCP FAOC

  48. ZY 100175096Viva Zyprexa

  49. ZY 100175096 Viva ZyprexaPCPs/GPs = financial opportunities